Jiangsu Xikang Technology Co., Ltd. announced that it will receive CNY 140 million in funding from returning investor Shanghai Labway Clinical Laboratory Co., Ltd. on August 24, 2022. The transaction is approved at the eighth meeting of the third board of directors.